Canada’s Drug Agency is collaborating with Choosing Wisely Canada to better understand the appropriate use of antipsychotics in long-term care settings.
We invite people with extensive personal or professional experience within the long-term care system in Canada, to connect with us to be informed of this project as it continues.
If you have an interest in this topic, and you wish to be informed of any updates or opportunities to be involved, such as providing feedback on draft documents or attending a webinar, please complete the form below